There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Show figures in :Show figures in :
Data is unavailable
Data is unavailable
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net worth | 704.47 | 656.56 | 698.78 | 692.10 | 727.65 | 687.10 | 706.69 | 647.58 | 976.79 | 945.71 | 91.27 | 56.73 | 95.00 | 122.53 | 123.06 | 111.78 | 40.52 | 57.37 | 34.92 |
| Fixed assets | 586.03 | 591.95 | 605.31 | 564.44 | 535.66 | 576.57 | 498.14 | 475.97 | 684.33 | 586.48 | 474.43 | 237.60 | 227.26 | 229.76 | 210.76 | 184.95 | 106.85 | 43.54 | 19.32 |
| Debt | 446.38 | 451.28 | 397.90 | 314.89 | 224.70 | 343.41 | 325.07 | 304.61 | 415.67 | 312.25 | 473.42 | 418.11 | 311.27 | 268.77 | 189.38 | 175.12 | 96.99 | 25.21 | 4.36 |
View detailed balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 83.36 | 30.60 | 16.81 | 30.60 | 114.75 | 115.33 | 116.02 | 45.24 | -7.19 | -0.05 | -23.55 | -44.79 | -3.82 | 21.48 | 49.64 | 16.90 | -4.98 |
| Investing | -24.78 | -5.92 | -64.96 | -95.57 | 9.65 | -72.27 | -67.70 | 7.17 | -116.18 | -315.83 | -154.69 | -79.96 | -54.89 | -66.78 | -71.77 | -4.06 | -29.37 |
| Financing | -60.73 | -1.44 | 32.23 | 67.26 | -138.75 | -42.75 | -20.08 | -56.96 | 147.44 | 308.70 | 179.41 | 145.54 | 34.70 | 61.94 | 16.51 | -5.95 | 34.32 |
SeQuent is an animal health company providing veterinary APIs, finished formulations, and analytical services, operating globally through group facilities and subsidiaries.
The group operates across over 90 countries with 7 manufacturing facilities supporting global supply, per general information notes.
Consolidated revenue from operations was Rs 1,551.37 crore, with year-on-year growth of 13.26% as disclosed in the Board’s Report.
